Evidence map›Paper›PMID 32829009›Full record

ArticleCancer letters2020

E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1.

Kien Pham, Do Huynh, Le Le, Daniel Delitto, Lei Yang, Jing Huang, Yibin Kang, Michael B Steinberg, Jieliang Li, Lanjing Zhang and 4 more

Open access · greenAbstract read
In one paragraph

Article in Cancer letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Kien PhamDepartment of Pathology, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: kien.pham@yale.edu.
Do HuynhDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
Le LeDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
Daniel DelittoDepartment of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Lei YangDepartment of Pathology, Yale School of Medicine, Yale University, New Haven, CT, USA.
Jing HuangDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
Yibin KangDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
Michael B SteinbergDepartment of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
Jieliang LiDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
Lanjing ZhangDepartment of Pathology, Immunology & Laboratory Medicine, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
Dongfang LiuDepartment of Pathology, Immunology & Laboratory Medicine, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
Moon-Shong TangDepartment of Environment Medicine, New York University School of Medicine, New York University, Tuxedo Park, NY, USA.
Chen LiuDepartment of Pathology, Yale School of Medicine, Yale University, New Haven, CT, USA.
He WangDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA; Department of Pathology, Immunology & Laboratory Medicine, New Jersey Medical School, Rutgers University, Newark, NJ, USA. Electronic address: hw423@rwjms.rutgers.edu.
Rutgers, The State University of New Jersey · USYale University · USJohns Hopkins University · USNew York University · USPrinceton University · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Clinical and Laboratory Research Training for Surgical OncologistsT32CA126607 · NCI · JOHNS HOPKINS UNIVERSITY · PI CAMERON, ANDREW M. · 2008 to 2024
$6.0M
Bispecific cytotoxic lymphocytes in HIV-related lymphomaR21HL125018 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2015 to 2016
$449k
NCI NIH HHS P30 CA072720NCI NIH HHS T32 CA126607
6 · The paper itself

Abstract

Young women represent a target of E-cigarette (E-cig) companies, raising concern for potential connections with breast cancer (BC) that have not yet been elucidated. We hypothesized that E-cig promotes BC development and lung metastasis possibly through BC-monocyte/tumor-associated macrophage (TAM) crosstalk via CCL5 and V-CAM-1 axes. We demonstrated that E-cig promoted the infiltration of circulating monocytes in mammary fat pad (MFP) model. Furthermore, E-cig exposure significantly enhanced BC cell growth in MFP tumor and metastatic lung colonization; immunohistochemical stains illustrated the increase of TAMs infiltration, reduced BC cell apoptosis and increased proliferation index after E-cig exposure. In vitro studies show E-cig vapor condensate (EVC) treatment upregulated protein expressions of CCL5, V-CAM-1, and other pro-tumorigenic factors in BC cells. Mechanistically, co-culture system demonstrated both EVC and macrophages independently stimulated BC cell growth and the migration via CCL5/CCR1/CCR5 axis. During metastasis, E-Cig exposure stimulated BC cell survival via direct interaction with infiltrated macrophages, regulated by VCAM-1 and integrin α

Indexed as

Electronic Nicotine Delivery SystemsAnimalsApoptosisBreast NeoplasmsCell CommunicationCell MovementCells, CulturedChemokine CCL5Disease ProgressionFemaleHumansLung NeoplasmsMiceMice, Inbred BALB CTumor-Associated MacrophagesTumor MicroenvironmentChemokine CCL5Vascular Cell Adhesion Molecule-1Breast cancerCCL5E-CigaretteLung metastasisMacrophagesV-CAM-1

Identifiers

PMID32829009
PMCPMC9703643
OpenAlexW3080458939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.